In our study, we demonstrated that pharmacological inhibition of USP10 using spautin-1 synergistically enhances the anti-tumor efficacy of cisplatin, significantly suppressing tumor growth and lung metastasis in preclinical mouse models. Here, USP10 is linked to neoplasm.